BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16772877)

  • 1. Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
    Yamamoto M; Suzuki N; Hatakeyama N; Mizue N; Hori T; Kuroiwa Y; Hareyama M; Oda T; Kudoh T; Nui A; Matsuno T; Hirama T; Yokoyama S; Dome JS; Tsutsumi H
    J Pediatr Hematol Oncol; 2006 May; 28(5):286-9. PubMed ID: 16772877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
    Koga Y; Matsuzaki A; Suminoe A; Hatano M; Saito Y; Kinoshita Y; Tajiri T; Taguchi T; Kohashi K; Oda Y; Tsuneyoshi M; Hara T
    Pediatr Blood Cancer; 2009 Jul; 52(7):888-90. PubMed ID: 19260106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapse.
    Hosoi H; Iehara T; Tsuchiya K; Misawa A; Miyaji M; Yagyu S; Koizumi M; Nishimura T; Tokiwa K; Iwai N; Yanagisawa A; Sugimoto T
    J Pediatr Surg; 2007 Oct; 42(10):E9-12. PubMed ID: 17923188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of metastatic rhabdoid tumor of the kidney.
    Wagner L; Hill DA; Fuller C; Pedrosa M; Bhakta M; Perry A; Dome JS
    J Pediatr Hematol Oncol; 2002; 24(5):385-8. PubMed ID: 12142788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-confined primitive neuroectodermal tumor arising from the kidney.
    Lam JS; Hensle TW; Debelenko L; Granowetter L; Tennenbaum SY
    J Pediatr Surg; 2003 Apr; 38(4):619-21. PubMed ID: 12677579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refining therapeutic strategies for patients with resistant Wilm's tumor.
    Marina NM; Wilimas JA; Meyer WH; Jones DP; Douglass EC; Pratt CB
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):296-300. PubMed ID: 7978044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
    N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.
    Athale UH; Duckworth J; Odame I; Barr R
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):651-63. PubMed ID: 19707161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant rhabdoid tumor of the kidney: significantly improved response to pre-operative treatment intensified with doxorubicin.
    Furtwängler R; Nourkami-Tutdibi N; Leuschner I; Vokuhl C; Niggli F; Kager L; Ebinger M; Frühwald MC; Graf N;
    Cancer Genet; 2014 Sep; 207(9):434-6. PubMed ID: 25242089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
    Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
    Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord compression and lung metastasis of Wilms' tumor in a pregnant adolescent.
    Corapcioglu F; Dillioğlugil O; Sarper N; Akansel G; Calişkan M; Arisoy AE
    Urology; 2004 Oct; 64(4):807-10. PubMed ID: 15491732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
    Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A
    Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group.
    van den Heuvel-Eibrink MM; van Tinteren H; Rehorst H; Coulombe A; Patte C; de Camargo B; de Kraker J; Leuschner I; Lugtenberg R; Pritchard-Jones K; Sandstedt B; Spreafico F; Graf N; Vujanic GM
    Pediatr Blood Cancer; 2011 May; 56(5):733-7. PubMed ID: 21370404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.
    Arndt CA; Hawkins DS; Meyer WH; Sencer SF; Neglia JP; Anderson JR
    Pediatr Blood Cancer; 2008 Jan; 50(1):33-6. PubMed ID: 17091486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
    Geyer JR; Sposto R; Jennings M; Boyett JM; Axtell RA; Breiger D; Broxson E; Donahue B; Finlay JL; Goldwein JW; Heier LA; Johnson D; Mazewski C; Miller DC; Packer R; Puccetti D; Radcliffe J; Tao ML; Shiminski-Maher T;
    J Clin Oncol; 2005 Oct; 23(30):7621-31. PubMed ID: 16234523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced malignant rhabdoid tumor of the ovary effectively responding to chemotherapy: a case report and review of the literature.
    Banzai C; Yahata T; Sasahara J; Kashima K; Fujita K; Nishikura K; Ajioka Y; Motoyama T; Tanaka K
    Gynecol Oncol; 2007 Apr; 105(1):261-5. PubMed ID: 17292455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.